Case studies of device recalls and field actions and key lessons learned

Case Studies of Device Recalls and Field Actions: Lessons Learned In the realm of medical devices, post-market surveillance is a critical area that ensures the safety and effectiveness of products after they have been released into the market. This tutorial serves as a comprehensive guide for regulatory, quality, clinical, and RA/QA professionals working with medical devices and combination products. It will explore case studies of device recalls and field actions, the relevant regulatory framework, and key lessons learned that can enhance compliance and safety in future product registrations. Understanding Post-Market Surveillance and MDR Requirements Post-market surveillance involves systematic monitoring of…

Continue Reading... Case studies of device recalls and field actions and key lessons learned

Designing complaint handling systems that feed effective PMS and MDR

Designing Complaint Handling Systems that Feed Effective PMS and MDR In the rapidly evolving field of medical devices, maintaining compliance with regulatory requirements is paramount. U.S. manufacturers must adhere to stringent guidelines set forth by the FDA, particularly regarding post-market surveillance (PMS) and Medical Device Reporting (MDR). This step-by-step tutorial outlines how to design effective complaint handling systems that not only meet these requirements but also strengthen overall product safety protocols. Understanding the Regulatory Framework The backbone of any effective complaint handling system begins with an understanding of the regulatory framework applicable to medical devices. In the United States, the…

Continue Reading... Designing complaint handling systems that feed effective PMS and MDR

Governance for safety review boards overseeing device PMS signals

Governance for Safety Review Boards Overseeing Device PMS Signals The governance of safety review boards for overseeing post-market surveillance (PMS) signals is an essential facet of regulatory compliance for medical devices. Regulatory, quality, clinical, and RA/QA professionals must be well-versed in the mechanisms of managing safety signals to safeguard public health while adhering to the stipulations of the US FDA. In this comprehensive tutorial, we delve into the intricate details of post-market surveillance, adverse event reporting, device recalls, and the methodologies utilized in the governance of safety review boards. Understanding Post-Market Surveillance and Its Importance Post-market surveillance (PMS) is an…

Continue Reading... Governance for safety review boards overseeing device PMS signals

Global coordination of US MDR, EU vigilance and other reporting regimes

Global coordination of US MDR, EU vigilance and other reporting regimes Global Coordination of US MDR, EU Vigilance and Other Reporting Regimes In the field of medical devices and combination products, ensuring safety and compliance is paramount, especially through effective post-market surveillance. This guide will explore the Federal Drug Administration (FDA) regulations, particularly focusing on post-market surveillance, Medical Device Reporting (MDR), corrections and removals, and how these efforts coordinate with European Union vigilance practices. By understanding the nuances of these regulations, professionals can better manage compliance and enhance patient safety. Understanding the FDA’s Post-Market Surveillance Obligations The FDA’s obligations regarding…

Continue Reading... Global coordination of US MDR, EU vigilance and other reporting regimes

Unique PMS challenges for SaMD, implants and home use medical devices

Unique PMS Challenges for SaMD, Implants and Home Use Medical Devices Understanding Post-Market Surveillance for Medical Devices Post-market surveillance (PMS) refers to the activities undertaken to monitor the safety, performance, and continued validity of medical devices after they have received regulatory approval. The significance of PMS cannot be overstated, particularly for Software as a Medical Device (SaMD), implants, and home-use devices, which come with unique challenges. These devices often function under different operating conditions than those assumed during pre-market testing, leading to potential unrecognized risks. PMS practices are guided primarily by 21 CFR 803, which outlines the reporting requirements for…

Continue Reading... Unique PMS challenges for SaMD, implants and home use medical devices

Integrating PMS data into CAPA and design risk management updates

Integrating PMS Data into CAPA and Design Risk Management Updates Post-Market Surveillance (PMS) is essential for ensuring the safety and effectiveness of medical devices once they are on the market. As part of compliance with 21 CFR 803, companies must be diligent in watching for safety signals and understanding the implications of their Medical Device Reporting (MDR) obligations. Furthermore, integrating PMS data into Corrective and Preventive Actions (CAPA) and design risk management processes is fundamental for maintaining regulatory compliance and ensuring patient safety. This article presents a step-by-step tutorial on how to effectively integrate PMS data into CAPA and design…

Continue Reading... Integrating PMS data into CAPA and design risk management updates

KPIs to measure post market surveillance effectiveness for device portfolios

Key Performance Indicators to Measure Post Market Surveillance Effectiveness for Device Portfolios Post market surveillance (PMS) is an essential aspect of medical device regulation aimed at ensuring that devices remain safe and effective throughout their lifecycle. A robust PMS system enables manufacturers to respond promptly to safety signals, enhance product quality, and ensure compliance with regulatory requirements such as those specified in 21 CFR 803. In this guide, we will outline key performance indicators (KPIs) that can be employed to assess the effectiveness of post market surveillance activities for medical device portfolios. Understanding Post Market Surveillance and Its Regulatory Importance…

Continue Reading... KPIs to measure post market surveillance effectiveness for device portfolios

Auditor and inspector focus areas when reviewing PMS and MDR systems

Auditor and inspector focus areas when reviewing PMS and MDR systems Auditor and inspector focus areas when reviewing PMS and MDR systems Understanding the Importance of Post-Market Surveillance (PMS) and Medical Device Reporting (MDR) Post-Market Surveillance (PMS) is a crucial component in the lifecycle of medical devices and is defined under the regulatory framework set forth by the FDA. Its primary objective is to collect and analyze information about the performance of medical devices after they have been marketed. It provides a mechanism for identifying safety signals and ensuring long-term safety and efficacy of devices in use. Regulatory, quality, clinical,…

Continue Reading... Auditor and inspector focus areas when reviewing PMS and MDR systems

Preparing communications to clinicians, distributors and patients during recalls

Preparing Communications to Clinicians, Distributors and Patients During Recalls Effective communication during the recall of medical devices is critical for ensuring safety and compliance with regulatory requirements. Medical device manufacturers are accountable for maintaining effective post-market surveillance, promptly managing MDR corrections and removals, and effectively communicating critical information to clinicians, distributors, and patients. Understanding the regulatory framework that governs these communications is essential for regulatory, quality, clinical, and RA/QA professionals working with medical devices and combination products. Understanding the Regulatory Framework for Post-Market Surveillance The U.S. Food and Drug Administration (FDA) requires that medical device manufacturers establish and maintain comprehensive…

Continue Reading... Preparing communications to clinicians, distributors and patients during recalls

Documentation expectations for corrections, removals and recall decisions

Documentation Expectations for Corrections, Removals, and Recall Decisions Medical devices are subject to rigorous regulatory oversight meant to ensure their safety and efficacy. An essential part of this oversight involves the documentation expectations surrounding corrections, removals, and recall decisions that arise in the post-market phase of a medical device’s lifecycle. Understanding these expectations is critical not only for compliance with 21 CFR 803 but also for aligning with global vigilance requirements and ensuring patient safety. This guide offers a step-by-step tutorial for regulatory, quality, clinical, and RA/QA professionals. Understanding Post-Market Surveillance and MDR Reporting Post-market surveillance is a crucial aspect…

Continue Reading... Documentation expectations for corrections, removals and recall decisions